Skip to main content

Table 4 Antibiotic susceptibility profiles of NMEC and HFEC. Number of isolates (stated as percentages) in NMEC and HFEC were categorized as Sensitive (S), Intermediate (I) or Resistant (R) according to CLSI standards

From: Characterizing the pathotype of neonatal meningitis causing Escherichia coli (NMEC)

Antibiotic NMEC    HFEC   
  S I R S I R
Ampicillin 50.94 3.773585 45.28 64.58 4.167 31.25
Cefazolin 96.23 0 3.77 93.75 0 6.25
Cefepime 96.23 0 3.77 100 0 0
Cefotaxime 90.57 0 9.43 93.75 0 6.25
Cefoxitin 90.57 0 9.43 95.83 2.08 2.08
Cefpodoxime 90.57 0 9.43 9.16 0 8.33
Ceftazidime 90.57 0 9.43 93.75 0 6.25
Ceftriaxone 88.68 1 9.43 91.66 2.08 6.25
Cephalothin 100 0 0 100 0 1
Ciprofloxacin 100 0 0 100 0 0
Gentamicin 100 0 0 100 0 0
Imipenem 100 0 0 100 0 0
Meropenem 100 0 0 100 0 0
Piperacillin/Tazobactam 100 0 0 100 0 0
Ceftazidime/Clavulanic acid 100 0 0 100 0 0
Amikacin 100 0 0 100 0 0
Amoxicillin 100 0 0 60.41 2.083 37.5
Chloramphenicol 94.34 0 5.66 97.91 2.083 0
Sulfa/Trimethoprim 81.13 0 18.86 93.75 0 6.25
Kanamycin 86.79 2 9.433 100 0 0
Nalidixic acid 96.23 0 3.773 81.25 0 18.75
Sulfisoxazole 67.92 3 14 68.75 16.66 14.58
Tetracycline 81.13 0 10 91.66 0 8.33